| Emma Considine, DO | |
|
2500 Ne Neff Rd, Bend, OR 97701-6015 | |
| (541) 706-7734 | |
| (541) 706-7794 |
| Full Name | Emma Considine |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 11 Years |
| Location | 2500 Ne Neff Rd, Bend, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447695226 | NPI | - | NPPES |
| 500792790 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | DO203085 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Charles Health System Inc | 8729111513 | 206 |
News Archive
Sometimes vaccines need a little help to protect people against infectious diseases.
A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. In a study published this month in Blood, the Penn team describes the strategy, based on the oldest part of the human immune system - called "complement" - that could turn out to be less costly and more effective for the majority of patients with a rare blood disorder.
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. "It's a discovery that offers exciting new avenues for controlling influenza, since until now attempts to target the virus itself have proven challenging, especially in the face of emerging new strains of the virus," says Saleh, who is also a researcher at the Research Institute of the McGill University Health Centre.
Politico: Experts are questioning the virtues of the three-year Medicare "doc fix" that would stave off cuts to Medicare doctors' pay but set up a larger fight down the road. ... In health policy circles, the 'doc fix' has become emblematic of Washington's worst habits: a potentially solvable policy problem run amok for about a decade now, bogged down in pure politics and accounting gimmicks. The 'doc fix,' a last-minute infusion of funds to head off a looming doctor pay cut under Medicare, hits the floor this week via the tax extenders bill ..."
› Verified 4 days ago
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982621447 PECOS PAC ID: 3870402852 Enrollment ID: O20040112000045 |
News Archive
Sometimes vaccines need a little help to protect people against infectious diseases.
A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. In a study published this month in Blood, the Penn team describes the strategy, based on the oldest part of the human immune system - called "complement" - that could turn out to be less costly and more effective for the majority of patients with a rare blood disorder.
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. "It's a discovery that offers exciting new avenues for controlling influenza, since until now attempts to target the virus itself have proven challenging, especially in the face of emerging new strains of the virus," says Saleh, who is also a researcher at the Research Institute of the McGill University Health Centre.
Politico: Experts are questioning the virtues of the three-year Medicare "doc fix" that would stave off cuts to Medicare doctors' pay but set up a larger fight down the road. ... In health policy circles, the 'doc fix' has become emblematic of Washington's worst habits: a potentially solvable policy problem run amok for about a decade now, bogged down in pure politics and accounting gimmicks. The 'doc fix,' a last-minute infusion of funds to head off a looming doctor pay cut under Medicare, hits the floor this week via the tax extenders bill ..."
› Verified 4 days ago
| Entity Name | Bend Memorial Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699827477 PECOS PAC ID: 7214936533 Enrollment ID: O20061215000022 |
News Archive
Sometimes vaccines need a little help to protect people against infectious diseases.
A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. In a study published this month in Blood, the Penn team describes the strategy, based on the oldest part of the human immune system - called "complement" - that could turn out to be less costly and more effective for the majority of patients with a rare blood disorder.
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. "It's a discovery that offers exciting new avenues for controlling influenza, since until now attempts to target the virus itself have proven challenging, especially in the face of emerging new strains of the virus," says Saleh, who is also a researcher at the Research Institute of the McGill University Health Centre.
Politico: Experts are questioning the virtues of the three-year Medicare "doc fix" that would stave off cuts to Medicare doctors' pay but set up a larger fight down the road. ... In health policy circles, the 'doc fix' has become emblematic of Washington's worst habits: a potentially solvable policy problem run amok for about a decade now, bogged down in pure politics and accounting gimmicks. The 'doc fix,' a last-minute infusion of funds to head off a looming doctor pay cut under Medicare, hits the floor this week via the tax extenders bill ..."
› Verified 4 days ago
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023331303 PECOS PAC ID: 8729111513 Enrollment ID: O20100730000227 |
News Archive
Sometimes vaccines need a little help to protect people against infectious diseases.
A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. In a study published this month in Blood, the Penn team describes the strategy, based on the oldest part of the human immune system - called "complement" - that could turn out to be less costly and more effective for the majority of patients with a rare blood disorder.
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. "It's a discovery that offers exciting new avenues for controlling influenza, since until now attempts to target the virus itself have proven challenging, especially in the face of emerging new strains of the virus," says Saleh, who is also a researcher at the Research Institute of the McGill University Health Centre.
Politico: Experts are questioning the virtues of the three-year Medicare "doc fix" that would stave off cuts to Medicare doctors' pay but set up a larger fight down the road. ... In health policy circles, the 'doc fix' has become emblematic of Washington's worst habits: a potentially solvable policy problem run amok for about a decade now, bogged down in pure politics and accounting gimmicks. The 'doc fix,' a last-minute infusion of funds to head off a looming doctor pay cut under Medicare, hits the floor this week via the tax extenders bill ..."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emma Considine, DO 1501 Ne Medical Center Dr, Bend, OR 97701-6051 Ph: (541) 382-4900 | Emma Considine, DO 2500 Ne Neff Rd, Bend, OR 97701-6015 Ph: (541) 706-7734 |
News Archive
Sometimes vaccines need a little help to protect people against infectious diseases.
A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. In a study published this month in Blood, the Penn team describes the strategy, based on the oldest part of the human immune system - called "complement" - that could turn out to be less costly and more effective for the majority of patients with a rare blood disorder.
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. "It's a discovery that offers exciting new avenues for controlling influenza, since until now attempts to target the virus itself have proven challenging, especially in the face of emerging new strains of the virus," says Saleh, who is also a researcher at the Research Institute of the McGill University Health Centre.
Politico: Experts are questioning the virtues of the three-year Medicare "doc fix" that would stave off cuts to Medicare doctors' pay but set up a larger fight down the road. ... In health policy circles, the 'doc fix' has become emblematic of Washington's worst habits: a potentially solvable policy problem run amok for about a decade now, bogged down in pure politics and accounting gimmicks. The 'doc fix,' a last-minute infusion of funds to head off a looming doctor pay cut under Medicare, hits the floor this week via the tax extenders bill ..."
› Verified 4 days ago
Alanna Mozena, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Ashley Marie Twyman, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Dr. Gilbert B. Lee, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1558 Sw Nancy Way, Bend, OR 97702 Phone: 541-312-8679 | |
Ms. Christine Marie Pierson, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2965 Ne Conners Ave, Ste 280, Bend, OR 97701 Phone: 541-323-4269 | |
Dr. Michael N Harris, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-2811 | |
Gordon Jeremy Juriansz, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 | |
Dr. Ronald Daniel Rosen, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 918 Ne 5th St, Bend, OR 97701 Phone: 541-388-3804 Fax: 541-388-3856 |